Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma
F Tang, Y Lu, Y Ge, J Shang… - Journal of International …, 2020 - journals.sagepub.com
Objective To investigate the safety and efficacy of chimeric antigen receptor T (CAR-T) cell
infusion in patients with refractory multiple myeloma (MM). Methods Sixteen patients …
infusion in patients with refractory multiple myeloma (MM). Methods Sixteen patients …
Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma.
F Tang, Y Lu, Y Ge, J Shang, X Zhu - The Journal of International …, 2020 - europepmc.org
Objective To investigate the safety and efficacy of chimeric antigen receptor T (CAR-T) cell
infusion in patients with refractory multiple myeloma (MM). Methods Sixteen patients …
infusion in patients with refractory multiple myeloma (MM). Methods Sixteen patients …
[PDF][PDF] and Xiaming Zhu
F Tang, Y Lu, Y Ge, J Shang - Journal of International Medical Research - academia.edu
Objective: To investigate the safety and efficacy of chimeric antigen receptor T (CAR-T) cell
infusion in patients with refractory multiple myeloma (MM). Methods: Sixteen patients …
infusion in patients with refractory multiple myeloma (MM). Methods: Sixteen patients …
Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma
F Tang, Y Lu, Y Ge, J Shang… - The Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective To investigate the safety and efficacy of chimeric antigen receptor T (CAR-T) cell
infusion in patients with refractory multiple myeloma (MM). Methods Sixteen patients …
infusion in patients with refractory multiple myeloma (MM). Methods Sixteen patients …
[HTML][HTML] Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma
F Tang, Y Lu, Y Ge, J Shang, X Zhu - The Journal of International …, 2020 - ncbi.nlm.nih.gov
Objective To investigate the safety and efficacy of chimeric antigen receptor T (CAR-T) cell
infusion in patients with refractory multiple myeloma (MM). Methods Sixteen patients …
infusion in patients with refractory multiple myeloma (MM). Methods Sixteen patients …